US 4,781,693 AGranted

Insulin dispenser for peritoneal cavity

AssigneeMinntech Corporation

InventorsFelix J. Martinez, Larry E. Fuller, Louis C. Cosentino

Life of this patent

Estimating the term…

Loading patent…

Abstract

An implant device for introduction of insulin into the peritoneal cavity which permits a flexible catheter to be removed and replaced without invasive surgery. The catheter is passed through a substantially rigid percutaneous body and a distally extending catheter conduit which together form a continuous conduit from the body exterior through the peritoneal wall. A polytetrafluoroethylene polymer sleeve allows tissue ingrowth to secure the body to the epidermis. A polyethylene terephthalate portion of the sleeve provides tissue ingrowth to stabilize the implant and prevent extrusion from the dermis. The catheter is associated with the percutaneous tubular body so as to be removable and replaceable through the conduit thereformed after implantation. The catheter preferably terminates within the interior cavity of the percutaneous body and is sealed from the environment by means of a septum closure within the device cavity. A sponge saturated with antiseptic is fitted in the body recess above the septum and is closed off from the environment by a penetrable cap member. The saturated sponge prevents the introduction of bacteria into the peritoneum.

Claims2

Dependent claims

A percutaneous implant device for providing access to the peritoneal cavity comprising:

a substantially rigid, tubular percutaneous body of biologically compatible material which extends through the skin and peritoneum when implanted so as to provide means for accessing the peritoneal cavity through the interior of said device;
flexible, subcutaneous catheter means associated with said tubular percutaneous body for providing fluid communication between the body exterior and the peritoneal cavity;
porous tissue ingrowth means for anchoring the device to a patient's body said porous tissue ingrowth means including a porus collar of polytetrafluoroethylene overlaying said tubular percutaneous body on the portion of said tubular body to be embedded within the epidermis and a porous collar of polyethylene terephthalate overlaying said tubular percutaneous body between said polytetrafluoroethylene collar and said catheter;
an elastomeric septum member occupying a portion of the tubular portion of said body, and means for holding said septum member in a sealed relationship within the interior of said tubular percutaneous body, said septum and said body defining an excutaneous cavity within the device;
sponge means within said excutaneous cavity for maintaining sterility when saturated with an antiseptic solution;
and
a penetrable cap member adapted to be joined to said body for sealing said sponge means within said tubular percutaneous body of said device.

4 more elements

Dependencies are inferred from the claim text.

Facts

Application: 06/529,048Filed 2 Sep 1983
Granted: 1 Nov 1988
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61M 39/0247
Access sites: transcutaneous or percutaneous access sites to the inside of the body
A61M 39/06
Access sites: haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
A61M 2039/0255
Transcutaneous or percutaneous access sites to the inside of the body: for access to the gastric or digestive system
A61M 2039/0273
Transcutaneous or percutaneous access sites to the inside of the body: for introducing catheters into the body